Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

Multicenter Study for Evaluation of Efficacy and Safety of Perennial Specific Immunotherapy With a Depot House Dust Mite Allergen Extract (D. Pteronyssinus 100%) in Patients With House Dust Mite Sensitivity

The trial is performed to assess efficacy and safety of Novo-Helisen Depot in allergic Rhinoconjunctivitis

Inclusion Criteria:

• Positive skin prick test to house dust mite,
• Positive RAST test to house dust mite,
• Positive provocation test result to house dust mite,

Exclusion Criteria:

• Serious chronic diseases,
• Other perennial allergies